Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
Kerry J Williams, A Craig LockhartDepartment of Medicine, Division of Medical Oncology, Washington University School of Medicine St. Louis, MO, USAAbstract: The tumor biology targeted therapies have improved outcomes in colorectal cancer (CRC). The epidermal growth factor receptor (EGFR) inhibitors...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-06-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/targeting-colorectal-cancer-with-anti-epidermal-growth-factor-receptor-a3312 |